5 Documents disponibles écrits par cet auteur
Identifying the co-occurrence of drug use and mental health disorders in the same individuals is essential for effective treatment of their drug use problems. Reviewing the available information on psychiatric co-morbidity among drug users in Eu[...]
Concerns about the availability and use of methamphetamine in Europe have been growing for some time. Historically, the use of methamphetamine has been confined largely to the Czech Republic and Slovakia; however, recent signs of the spread of m[...]
This document is a summary of the concepts and definitions in the revised area. Detailed background information about the process of revision can be found in two related documents. The changes are, for the most part, related to the theoretical c[...]
OEDT = EMCDDA ; D. THANKI ; J. MATIAS ; P. GRIFFITHS ; A. NOOR ; D. OLSZEWSKI ; R. SIMON ; J. VICENTE | 2012
RapportThis report brings together, for the first time in Europe, an integrated overview of the prevalence of intensive cannabis use, defined as daily or almost daily cannabis use (use on 20 or more days in the month preceding survey). Self-reported da[...]
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; D. THANKI ; E. KALAMARA ; A. NOOR ; L. MONTANARI ; J. VICENTE | 2015
Document texte diversSome drug users go on to develop more severe forms of use, defined by the EMCDDA as 'high-risk drug use': 'recurrent drug use that is causing actual harms (negative consequences) to the person (including dependence, but also other health, psycho[...]
Historique
